Tilray Brands, Inc.(TLRY)

Drug Manufacturers - Specialty & Generic · Leamington, ON

$3.79+0.06 (+1.75%)

Delayed quote: Oct 6, 2026, 3:35 PM EDT

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T19:38:25.810Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:38:25.810Z.

Quote observation: 2026-10-06T19:35:09.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-05-31: -1.334
Quote price: 3.785

FMP input reference: e34e8fdf56cc8068b10795b2cd23ca1cf428d99faa8853e43d8e56f6a2fe063d

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

TLRY Earnings Yield Metrics

EARNINGS YIELD

N/A

TLRY Competitors' Earnings Yield

TLRY

Tilray Brands, Inc.

Current

Market Cap

$423.28M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SPRY

ARS Pharmaceuticals, Inc.

vs TLRY

Market Cap

$422.04M

Earnings Yield

N/A

TTM Avg

0.52%

3Y Avg

0.52%

5Y Avg

0.52%

EDIT

Editas Medicine, Inc.

vs TLRY

Market Cap

$420.49M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TECX

Tectonic Therapeutic, Inc.

vs TLRY

Market Cap

$425.33M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEO

NeoGenomics, Inc.

vs TLRY

Market Cap

$429.18M

Earnings Yield

N/A

TTM Avg

4.67%

3Y Avg

2.17%

5Y Avg

1.96%

SENS

Senseonics Holdings, Inc.

vs TLRY

Market Cap

$419.58M

Earnings Yield

N/A

TTM Avg

14.15%

3Y Avg

14.15%

5Y Avg

14.15%

PRTA

Prothena Corporation plc

vs TLRY

Market Cap

$418.30M

Earnings Yield

N/A

TTM Avg

3.29%

3Y Avg

3.29%

5Y Avg

3.29%

MPLT

MapLight Therapeutics, Inc.

vs TLRY

Market Cap

$412.06M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NPCE

NeuroPace, Inc.

vs TLRY

Market Cap

$436.34M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ASMB

Assembly Biosciences, Inc.

vs TLRY

Market Cap

$439.25M

Earnings Yield

2.48%

TTM Avg

1.91%

3Y Avg

1.91%

5Y Avg

1.91%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Tilray Brands, Inc. (TLRY)	$423.28M	N/A	N/A	N/A	N/A
ARS Pharmaceuticals, Inc. (SPRY)vs ›	$422.04M	N/A	0.52%	0.52%	0.52%
Editas Medicine, Inc. (EDIT)vs ›	$420.49M	N/A	N/A	N/A	N/A
Tectonic Therapeutic, Inc. (TECX)vs ›	$425.33M	N/A	N/A	N/A	N/A
NeoGenomics, Inc. (NEO)vs ›	$429.18M	N/A	4.67%	2.17%	1.96%
Senseonics Holdings, Inc. (SENS)vs ›	$419.58M	N/A	14.15%	14.15%	14.15%
Prothena Corporation plc (PRTA)vs ›	$418.30M	N/A	3.29%	3.29%	3.29%
MapLight Therapeutics, Inc. (MPLT)vs ›	$412.06M	N/A	N/A	N/A	N/A
NeuroPace, Inc. (NPCE)vs ›	$436.34M	N/A	N/A	N/A	N/A
Assembly Biosciences, Inc. (ASMB)vs ›	$439.25M	2.48%	1.91%	1.91%	1.91%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

About Tilray Brands, Inc.

Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.

Leamington, ON

3,595 employees

www.tilray.com

Healthcare / Drug Manufacturers - Specialty & Generic